ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660313 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660313; 2) Community: the network communities that were significantly associated with the response to NSC 660313; 3) Molecule: the relationships between components within communities and NSC 660313; 4) MDR: the compounds that were significantly associated with the NSC 660313.

NSC Compound Enrichment Correlation
NSC 703763 Null 0.0490935610249067 0.16314197
NSC 724827 1,4-di-N-oxide-6,7-difluoro-2-ethylcarbonyl-3-trifluoromethy lquinoxaline 0.0490935610249067 0.33049387
NSC 726444 4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione 0.0490935610249067 0.073825863
NSC 740613 Imidazole-5-one deri 0.0490935610249067 0.17791131
NSC 754824 4-[4-(3-Methoxy-phenyl)-piperazin-1 -yl]-5H-pyrrolo[3,2-d]pyrimidine 0.0490935610249067 0.024003782
NSC 757098 Melphalan (USAN) 0.0490935610249067 0.18370194
NSC 758450 Mitoxantrone hydrochloride (USAN) 0.0490935610249067 0.17285096
NSC 1011 P-[[.ALPHA.-(8-HYDROXY-7-QUINOLYL)BENZYL]AMINO]BENZOIC ACID 0.049093561024907 0.084976864
NSC 105808 5,8-Quinolinedione, 6-amino-7-bromo- 0.049093561024907 0.19240898
NSC 123139 L-Cysteine, S-[(4-methylphenyl)diphenylmethyl]- (9CI) 0.049093561024907 0.39486214
Total:58  Current:56    [First] [Prev] [Next] [Last]